Patents by Inventor Morgan Sammons

Morgan Sammons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tailored combinatorial epigenetic therapies for P53 gain-of-function tumors
    Patent number: 11596636
    Abstract: The present invention provides compositions and methods for treating and preventing cancer. The invention comprises an inhibitor of epigenetic regulators, including MLL1, MLL2, MOZ, menin, WDR5, or a combination thereof. In one embodiment, the invention provides a personalized method of treating a cancer as dependent upon its epigenetic signature.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: March 7, 2023
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Shelley L. Berger, Xianxin Hua, Morgan Sammons, Jiajun Zhu
  • Tailored Combinatorial Epigenetic Therapies for P53 Gain-of-Function Tumors
    Publication number: 20160339035
    Abstract: The present invention provides compositions and methods for treating and preventing cancer. The invention comprises an inhibitor of epigenetic regulators, including MLL1, MLL2, MOZ, menin, WDR5, or a combination thereof. In one embodiment, the invention provides a personalized method of treating a cancer as dependent upon its epigenetic signature.
    Type: Application
    Filed: January 14, 2015
    Publication date: November 24, 2016
    Inventors: Shelley L. Berger, Xianxin Hua, Morgan Sammons, Jiajun Zhu